Clinical Research Directory
Browse clinical research sites, groups, and studies.
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Sponsor: Oculis
Summary
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).
Official title: A Randomized, Double-masked, Placebo-controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients With Optic Neuritis (ON)
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2026-05-28
Completion Date
2028-12
Last Updated
2026-06-03
Healthy Volunteers
No
Conditions
Interventions
Privosegtor
Privosegtor (OCS-05) 3 mg/kg/day IV for 5 treatment days
Methylprednisolone
Methylprednisolone 1 g/day IV for 5 treatment days
Placebo
0.9% sodium chloride (NaCl) solution IV for 5 treatment days
Locations (1)
Neuro-Eye Clinical Trials
Houston, Texas, United States